Investor Type | Firm |
Industries | Healthcare (& Wellness) • Investment Management • Life Science |
Stages | Early |
Investing | United States |
Investment Range | $1,100,000 - $11,700,000 |
Gore Range Capital is a venture capital firm based in New York, New York that was founded in 2015. The firm primarily operates within the healthcare industry, investing in early-stage businesses related to skin health. They focus on leveraging their extensive experience in healthcare sectors—spanning operational, clinical, and scientific expertise—to drive innovation and growth in their portfolio companies. Gore Range Capital specializes in hands-on investing and works closely with industry pioneers to bring new skin health solutions to market. Their investment strategy emphasizes areas intersected by inflammatory, autoimmune, infectious, and lifestyle diseases, as well as microbiome dysbiosis and mental health—all of which significantly impact skin health and general well-being. The firm's investment ecosystem spans various stages of product development and market readiness, covering facets like enabling IT & devices, diagnostics, enhancement, regeneration, treatment, and prevention. Gore Range's investment thesis includes providing operational guidance to ventures coupled with strategic and financial oversight, thus blending the assertive nature of private equity with nurturing early-stage ventures commonly associated with venture capital. The fund's reported investment ranges from a minimum of $1,100,000 to a maximum of $11,700,000, with a specialty in identifying and nurturing start-ups that show potential for significant market impact. This focus has led to a portfolio that includes various companies at different stages, from initial seed funding to more advanced stages and exits through IPOs.